Kristina Kurbatova
Research Subjects
Kristina Kurbatova has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Laura G. Pivazyan
V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
7 shared publications A.A. Stepanian
Academy of Women’s Health and Endoscopic Surgery
5 shared publications- Leila V. Adamyan
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of the Ministry of Healthcare of Russian Federation
5 shared publications - K.S. Mailova
Russian University of Medicine
4 shared publications A.A. Osipova
Russian University of Medicine
2 shared publications- Alexandra Vyacheslavovna Asaturova
National Medical Research Center for Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Oparina St., 4, 117513 Moscow, Russia
2 shared publications
Latest Publications
- 14 October 2026
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 96 (4) , e70331
Macrophage Polarization and Metabolic Reprogramming in Endometriosis: Mechanisms and Therapeutic Implications
This review synthesizes evidence on macrophage roles, polarization (M1/M2), and immunometabolic/signaling pathways in endometriosis, outlining therapeutic implications. We searched PubMed, Cochrane Library, ClinicalTrials.gov, Scopus, Embase, and Google Scholar. Available evidence demonstrates increased macrophage accumulation and substantial heterogeneity across the eutopic endometrium, peritoneal fluid, and established endometriotic lesions. Rather than undergoing a uniform shift from an M1 to an M2 phenotype, endometriosis‐associated macrophages acquire overlapping inflammatory, immunoregulatory, angiogenic, phagocytic, metabolic, and profibrotic programs. Endometriotic epithelial and stromal cells regulate macrophage recruitment and activation through estrogen receptor β–NF‐κB–CCL2 signaling, IL‐17A‐ and TNF‐α‐dependent cytokine production, extracellular‐vesicle‐mediated microRNA transfer, and lactate‐driven METTL3–Trib1–ERK/STAT3 signaling. The CCL2/MCP‐1–CCR2 axis further links monocyte recruitment with inflammatory signaling and the invasive behavior of endometriotic cells, whereas TET3‐mediated suppression of let‐7 microRNAs sustains disease‐associated macrophage activation. Functionally, macrophages contribute to defective clearance of displaced endometrial tissue, ectopic cell survival, angiogenesis, fibrosis, neuroimmune sensitization, pain, and impaired reproductive function. These findings support an immunometabolic model in which macrophage plasticity drives lesion establishment, progression, neuroangiogenesis, pain, and infertility. Therapeutically, targeting macrophage polarization and metabolism—via glycolytic and mitochondrial pathways, lactate signaling, or epitranscriptomic regulators—may restore immune homeostasis and limit disease progression. Further translational studies are needed to validate biomarkers and develop macrophage‐directed interventions.
- 14 October 2026
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 96 (4) , e70331
Macrophage Polarization and Metabolic Reprogramming in Endometriosis: Mechanisms and Therapeutic Implications
This review synthesizes evidence on macrophage roles, polarization (M1/M2), and immunometabolic/signaling pathways in endometriosis, outlining therapeutic implications. We searched PubMed, Cochrane Library, ClinicalTrials.gov, Scopus, Embase, and Google Scholar. Available evidence demonstrates increased macrophage accumulation and substantial heterogeneity across the eutopic endometrium, peritoneal fluid, and established endometriotic lesions. Rather than undergoing a uniform shift from an M1 to an M2 phenotype, endometriosis‐associated macrophages acquire overlapping inflammatory, immunoregulatory, angiogenic, phagocytic, metabolic, and profibrotic programs. Endometriotic epithelial and stromal cells regulate macrophage recruitment and activation through estrogen receptor β–NF‐κB–CCL2 signaling, IL‐17A‐ and TNF‐α‐dependent cytokine production, extracellular‐vesicle‐mediated microRNA transfer, and lactate‐driven METTL3–Trib1–ERK/STAT3 signaling. The CCL2/MCP‐1–CCR2 axis further links monocyte recruitment with inflammatory signaling and the invasive behavior of endometriotic cells, whereas TET3‐mediated suppression of let‐7 microRNAs sustains disease‐associated macrophage activation. Functionally, macrophages contribute to defective clearance of displaced endometrial tissue, ectopic cell survival, angiogenesis, fibrosis, neuroimmune sensitization, pain, and impaired reproductive function. These findings support an immunometabolic model in which macrophage plasticity drives lesion establishment, progression, neuroangiogenesis, pain, and infertility. Therapeutically, targeting macrophage polarization and metabolism—via glycolytic and mitochondrial pathways, lactate signaling, or epitranscriptomic regulators—may restore immune homeostasis and limit disease progression. Further translational studies are needed to validate biomarkers and develop macrophage‐directed interventions.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (3)
The role of laser capture microdissection in the molecular-genetic investigation of endometriosis (Literature review and own experience)
Endometriosis is a gynecological disease affecting more than 190 million women of reproductive age worldwide, characterized by a complex molecular pathophysiology encompassing genetic, epigenetic, inflammatory, and immunological components. A fundamental methodological challenge in the study of endometriosis is the cellular heterogeneity of ectopic lesions: conventional analysis of bulk tissue specimens reflects averaged molecular profiles of mixed cell populations comprising glandular epithelium, stroma, fibrous and muscular tissue, and immune microenvironmental cells, substantially impeding the identification of cell-specific molecular alterations. This article presents an analysis of the capabilities of laser capture microdissection as a technology for the selective isolation of cell populations from heterogeneous tissues, enabling researchers to overcome this limitation. The methodological principles of the technology are described in detail, including critical parameters of biological material preparation, integration with downstream molecular analysis platforms, and the specificities of protocol standardization and validation across different tissue types. The broad applicability of laser capture microdissection in contemporary biomedical research is reviewed. Particular emphasis is placed on its application in endometriosis research specifically: data on transcriptomic profiling and differential gene expression analysis in the epithelial and stromal components of ectopic lesions are described; studies employing next-generation sequencing aimed at investigating somatic mutations, clonality, and mutational profiles of endometriotic cell populations are reviewed; and work in the field of multi-omics profiling across different disease forms is examined. The review also addresses existing methodological limitations of the technology and prospects for its further development, including integration with spatial transcriptomics, single-cell sequencing, and artificial intelligence-based approaches. Laser capture microdissection constitutes an instrument that opens fundamentally new avenues for investigating the molecular heterogeneity of endometriosis and establishing the foundation for the development of targeted, pathogenetically justified approaches to its diagnosis and treatment. This article also presents the authors’ own experience with the application of laser capture microdissection in endometriosis research. At the time of manuscript preparation, laser capture microdissection had been performed on 15 endometriotic lesion specimens obtained from patients with various forms of endometriosis, with separate isolation of epithelial and stromal components intended for subsequent molecular-genetic analysis.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 32 (3)
The role of laser capture microdissection in the molecular-genetic investigation of endometriosis (Literature review and own experience)
Endometriosis is a gynecological disease affecting more than 190 million women of reproductive age worldwide, characterized by a complex molecular pathophysiology encompassing genetic, epigenetic, inflammatory, and immunological components. A fundamental methodological challenge in the study of endometriosis is the cellular heterogeneity of ectopic lesions: conventional analysis of bulk tissue specimens reflects averaged molecular profiles of mixed cell populations comprising glandular epithelium, stroma, fibrous and muscular tissue, and immune microenvironmental cells, substantially impeding the identification of cell-specific molecular alterations. This article presents an analysis of the capabilities of laser capture microdissection as a technology for the selective isolation of cell populations from heterogeneous tissues, enabling researchers to overcome this limitation. The methodological principles of the technology are described in detail, including critical parameters of biological material preparation, integration with downstream molecular analysis platforms, and the specificities of protocol standardization and validation across different tissue types. The broad applicability of laser capture microdissection in contemporary biomedical research is reviewed. Particular emphasis is placed on its application in endometriosis research specifically: data on transcriptomic profiling and differential gene expression analysis in the epithelial and stromal components of ectopic lesions are described; studies employing next-generation sequencing aimed at investigating somatic mutations, clonality, and mutational profiles of endometriotic cell populations are reviewed; and work in the field of multi-omics profiling across different disease forms is examined. The review also addresses existing methodological limitations of the technology and prospects for its further development, including integration with spatial transcriptomics, single-cell sequencing, and artificial intelligence-based approaches. Laser capture microdissection constitutes an instrument that opens fundamentally new avenues for investigating the molecular heterogeneity of endometriosis and establishing the foundation for the development of targeted, pathogenetically justified approaches to its diagnosis and treatment. This article also presents the authors’ own experience with the application of laser capture microdissection in endometriosis research. At the time of manuscript preparation, laser capture microdissection had been performed on 15 endometriotic lesion specimens obtained from patients with various forms of endometriosis, with separate isolation of epithelial and stromal components intended for subsequent molecular-genetic analysis.
- 10 November 2025
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 31 (5) , 30-50
Cellular technologies in gynecology and reproductive medicine. (Literature review and own data)
Cellular technologies represent one of the most promising directions in gynecology and reproductive medicine, offering fundamentally novel approaches to the treatment of infertility and other reproductive function disorders. Unlike conventional therapeutic modalities, cell-based therapy targets the pathogenetic mechanisms of disease, promoting restoration of the structural and functional integrity of reproductive organs at the tissue and cellular levels. This article presents an analysis of contemporary cellular technologies employed in gynecology and reproductive medicine, including mesenchymal stem cells of various origins (bone marrow, adipose tissue, umbilical cord, placenta, menstrual blood, and endometrium), extracellular vesicles (exosomes and apoptotic bodies), platelet-rich plasma, microRNA therapy, tissue-engineered scaffolds, bioprinting, and organoid technologies. Particular emphasis is placed on the mechanisms of therapeutic action, encompassing immunomodulation, angiogenesis stimulation, fibrosis suppression, and paracrine secretion of bioactive factors. The results of clinical and experimental studies demonstrating the efficacy of cellular technologies in Asherman’s syndrome, thin endometrium, chronic endometritis, and premature ovarian insufficiency are examined in detail. Evidence indicates that mesenchymal stem cells are capable of restoring ovarian function, stimulating endometrial regeneration, enhancing implantation potential, and increasing pregnancy rates. Contemporary approaches, including bioengineering of extracellular vesicles, utilization of biocompatible scaffolds, and three-dimensional bioprinting, unveil novel opportunities for personalized regenerative therapy. The article also addresses existing limitations and future prospects for the development of cellular technologies, including the necessity for protocol standardization, implementation of large-scale controlled trials, and development of objective predictors of therapeutic response. Cellular technologies constitute a promising strategy for creating innovative, pathogenetically justified treatment methods aimed at restoring reproductive function and improving the efficacy of infertility management.
- 10 November 2025
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 31 (5) , 30-50
Cellular technologies in gynecology and reproductive medicine. (Literature review and own data)
Cellular technologies represent one of the most promising directions in gynecology and reproductive medicine, offering fundamentally novel approaches to the treatment of infertility and other reproductive function disorders. Unlike conventional therapeutic modalities, cell-based therapy targets the pathogenetic mechanisms of disease, promoting restoration of the structural and functional integrity of reproductive organs at the tissue and cellular levels. This article presents an analysis of contemporary cellular technologies employed in gynecology and reproductive medicine, including mesenchymal stem cells of various origins (bone marrow, adipose tissue, umbilical cord, placenta, menstrual blood, and endometrium), extracellular vesicles (exosomes and apoptotic bodies), platelet-rich plasma, microRNA therapy, tissue-engineered scaffolds, bioprinting, and organoid technologies. Particular emphasis is placed on the mechanisms of therapeutic action, encompassing immunomodulation, angiogenesis stimulation, fibrosis suppression, and paracrine secretion of bioactive factors. The results of clinical and experimental studies demonstrating the efficacy of cellular technologies in Asherman’s syndrome, thin endometrium, chronic endometritis, and premature ovarian insufficiency are examined in detail. Evidence indicates that mesenchymal stem cells are capable of restoring ovarian function, stimulating endometrial regeneration, enhancing implantation potential, and increasing pregnancy rates. Contemporary approaches, including bioengineering of extracellular vesicles, utilization of biocompatible scaffolds, and three-dimensional bioprinting, unveil novel opportunities for personalized regenerative therapy. The article also addresses existing limitations and future prospects for the development of cellular technologies, including the necessity for protocol standardization, implementation of large-scale controlled trials, and development of objective predictors of therapeutic response. Cellular technologies constitute a promising strategy for creating innovative, pathogenetically justified treatment methods aimed at restoring reproductive function and improving the efficacy of infertility management.
- 29 April 2025
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 31 (2)
Objectification of Pain in Patients with Endometriosis. (Literature review and own data)
The article focuses on the of methods for objectifying pain syndrome in patients with endometriosis. Endometriosis-related pain, including dysmenorrhea, dyspareunia, and chronic pelvic pain, is a clinically significant symptom of the disease that leads patients to seek medical help and significantly reduces their quality of life. The article discusses the pathophysiological mechanisms of pain related to inflammation, abnormal innervation of endometrial foci, peripheral, central and cross-sensitization. Special attention is paid to modern methods for diagnosing pain caused by endometriosis, including the use of modified pain scales (PainDetect), analysis of biomarkers (neurotransmitters, sex hormones, immune markers and metabolites) in patient’ biosamples and assessment of histological features of the endometriotic lesions. Modern neuroimaging techniques such as MRI tractography, neurography and resting-state functional MRI are also described. These methods allow for evaluation of the presence of neuropathic components in pain syndromes associated with endometriosis. The article also describes methods for objectifying pain in animal models of endometriosis and highlights the potential of non-invasive tests for assessing chronic pain in humans. It emphasizes the need for developing and actively applying pain objectification techniques in patients with endometriosis, as a key aspect of early diagnosis and timely treatment to prevent disease progression.
- 29 April 2025
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 31 (2)
Objectification of Pain in Patients with Endometriosis. (Literature review and own data)
The article focuses on the of methods for objectifying pain syndrome in patients with endometriosis. Endometriosis-related pain, including dysmenorrhea, dyspareunia, and chronic pelvic pain, is a clinically significant symptom of the disease that leads patients to seek medical help and significantly reduces their quality of life. The article discusses the pathophysiological mechanisms of pain related to inflammation, abnormal innervation of endometrial foci, peripheral, central and cross-sensitization. Special attention is paid to modern methods for diagnosing pain caused by endometriosis, including the use of modified pain scales (PainDetect), analysis of biomarkers (neurotransmitters, sex hormones, immune markers and metabolites) in patient’ biosamples and assessment of histological features of the endometriotic lesions. Modern neuroimaging techniques such as MRI tractography, neurography and resting-state functional MRI are also described. These methods allow for evaluation of the presence of neuropathic components in pain syndromes associated with endometriosis. The article also describes methods for objectifying pain in animal models of endometriosis and highlights the potential of non-invasive tests for assessing chronic pain in humans. It emphasizes the need for developing and actively applying pain objectification techniques in patients with endometriosis, as a key aspect of early diagnosis and timely treatment to prevent disease progression.
- 12 March 2025
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 31 (1)
Oxidative stress and antioxidant therapy in the treatment of premature ovarian insufficiency and improving the quality of life
Reactive oxygen species (ROS), at physiological concentrations, play a key role in regulating follicular growth, angiogenesis, and the biosynthesis of sex steroids in ovarian tissue. An imbalance between ROS and the body’s antioxidant system leads to oxidative stress (OS), which results in the degradation of both the quantitative and qualitative characteristics of oocytes. This review analyzes the relationship between OS and premature ovarian insufficiency (POI), highlights potential pathogenic mechanisms, and explores treatment approaches for POI through the modulation of OS levels via antioxidant therapy. It has been established that OS plays a significant role in genetic material damage, disrupts signaling pathways, transcription factor expression, and alters the oocyte microenvironment, ultimately leading to apoptosis of granulosa cells (GCs), disruption of meiotic division, reduction in mitochondrial DNA (mtDNA) content, and other pathophysiological changes that accelerate ovarian aging. Antioxidants, mesenchymal stem cells (MSCs), biological enzymes, and other antioxidant agents have the potential to slow down the progression of POI by reducing ROS concentrations, representing a promising direction for improving the quality of life and reproductive outcomes in patients with POI.
- 12 March 2025
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 31 (1)
Oxidative stress and antioxidant therapy in the treatment of premature ovarian insufficiency and improving the quality of life
Reactive oxygen species (ROS), at physiological concentrations, play a key role in regulating follicular growth, angiogenesis, and the biosynthesis of sex steroids in ovarian tissue. An imbalance between ROS and the body’s antioxidant system leads to oxidative stress (OS), which results in the degradation of both the quantitative and qualitative characteristics of oocytes. This review analyzes the relationship between OS and premature ovarian insufficiency (POI), highlights potential pathogenic mechanisms, and explores treatment approaches for POI through the modulation of OS levels via antioxidant therapy. It has been established that OS plays a significant role in genetic material damage, disrupts signaling pathways, transcription factor expression, and alters the oocyte microenvironment, ultimately leading to apoptosis of granulosa cells (GCs), disruption of meiotic division, reduction in mitochondrial DNA (mtDNA) content, and other pathophysiological changes that accelerate ovarian aging. Antioxidants, mesenchymal stem cells (MSCs), biological enzymes, and other antioxidant agents have the potential to slow down the progression of POI by reducing ROS concentrations, representing a promising direction for improving the quality of life and reproductive outcomes in patients with POI.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 30 (6)
Oxidative stress, ferroptosis, somatic mutations, antioxidant therapy, and endometriosis: a new perspective on the issue
The article focuses on the role of oxidative stress, ferroptosis, and antioxidant therapy in the pathogenesis and treatment of endometriosis — a gynecological condition affecting up to 10% of women of reproductive age. Oxidative stress and ferroptosis, which cause cellular damage and inflammation, play a significant role in the progression of endometriosis and may contribute to the accumulation of somatic mutations and DNA damage, exacerbating the pathological processes. Mutations in driver genes such as TP53, PTEN, and KRAS lead to dysregulation of cellular processes, enhancing the proliferation and invasion of endometrial cells. Antioxidant therapy is considered a promising approach in the treatment of endometriosis, in combination with surgical and pharmacological interventions. Antioxidants such as resveratrol, melatonin, curcumin, and N-acetylcysteine possess anti-inflammatory and antioxidant properties, helping to reduce oxidative stress, slow disease progression, and improve patient outcomes. The article emphasizes the need for further research to develop new treatment strategies aimed at reducing oxidative stress, preventing granulosa cell ferroptosis, and minimizing genetic damage, which may improve reproductive outcomes and the quality of life for women with endometriosis.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Human Reproduction
- Vol. 30 (6)
Oxidative stress, ferroptosis, somatic mutations, antioxidant therapy, and endometriosis: a new perspective on the issue
The article focuses on the role of oxidative stress, ferroptosis, and antioxidant therapy in the pathogenesis and treatment of endometriosis — a gynecological condition affecting up to 10% of women of reproductive age. Oxidative stress and ferroptosis, which cause cellular damage and inflammation, play a significant role in the progression of endometriosis and may contribute to the accumulation of somatic mutations and DNA damage, exacerbating the pathological processes. Mutations in driver genes such as TP53, PTEN, and KRAS lead to dysregulation of cellular processes, enhancing the proliferation and invasion of endometrial cells. Antioxidant therapy is considered a promising approach in the treatment of endometriosis, in combination with surgical and pharmacological interventions. Antioxidants such as resveratrol, melatonin, curcumin, and N-acetylcysteine possess anti-inflammatory and antioxidant properties, helping to reduce oxidative stress, slow disease progression, and improve patient outcomes. The article emphasizes the need for further research to develop new treatment strategies aimed at reducing oxidative stress, preventing granulosa cell ferroptosis, and minimizing genetic damage, which may improve reproductive outcomes and the quality of life for women with endometriosis.
- Open Access
- 18 March 2024
- Published by Elsevier in Journal of Endometriosis and Uterine Disorders
- Vol. 6
Hyaluronic acid in the prevention of adhesions after gynecological surgery: systematic review and meta-analysis
- 18 March 2024
- Published by Elsevier in Journal of Endometriosis and Uterine Disorders
- Vol. 6
Open AccessHyaluronic acid in the prevention of adhesions after gynecological surgery: systematic review and meta-analysis